ArticleJournal of asthma and allergy2022

Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled Trial.

Lavinia Davidescu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.